Tamar Howson - Jul 5, 2022 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Director
Signature
/s/ Brian G. Drazba, as attorney in fact
Stock symbol
MEIP
Transactions as of
Jul 5, 2022
Transactions value $
$0
Form type
4
Date filed
7/7/2022, 04:26 PM
Previous filing
Jun 17, 2022
Next filing
Jan 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +87.5K $0.00 87.5K Jul 5, 2022 Common Stock 87.5K $0.54 Direct F1
holding MEIP Stock Option (Right to Buy) 50K Jul 5, 2022 Common Stock 50K $2.95 Direct F3
holding MEIP Stock Option (Right to Buy) 60K Jul 5, 2022 Common Stock 60K $2.52 Direct F2
holding MEIP Stock Option (Right to Buy) 50K Jul 5, 2022 Common Stock 50K $3.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in equal monthly installments over twelve months.
F2 40,000 of the options vested on July 1, 2020, and are currently exercisable and 20,000 options will vest in equal monthly installments over thirty-six months beginning July 1, 2019.
F3 All of such options are presently exercisable.